Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor

Biochemical Journal

Volumn 458, Issue 1, 2014, Pages 95-107

  Chen, Tao ^a   Laurenzana, Elizabeth M ^a   Coslo, Denise M ^a   Chen, Fengming ^a   Omiecinski, Curtis J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Constitutive androstane receptor; Hepatocyte; Human; Lactacystin; MG 132; NR1I3; Proteasome

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; HEAT SHOCK PROTEIN 90; PLASMID DNA; PROTEASOME;

ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CLEARANCE; ELECTROPHORESIS; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL; MILK; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; UBIQUITINATION; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, CYTOPLASMIC AND NUCLEAR; UBIQUITINATION;

EID: 84892914168     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130685     Document Type: Article

References (48)

1. Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. and Negishi, M. (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274, 6043-6046
2. Qatanani, M. and Moore, D. D. (2005) CAR, the continuously advancing receptor, in drug metabolism and disease. Curr. Drug Metab. 6, 329-339
3. Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N. and Wolf, C. R. (2006) PXR and CAR: Nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab. Rev. 38, 515-597
4. Timsit, Y. E. and Negishi, M. (2007) CAR and PXR: The xenobiotic-sensing receptors. Steroids 72, 231-246
5. Moreau, A., Vilarem, M. J., Maurel, P. and Pascussi, J. M. (2008) Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol. Pharm. 5, 35-41
6. Gao, J. and Xie, W. (2010) PXR and CAR at the crossroad of drug metabolism and energy metabolism. Drug Metab. Dispos. 38, 2091-2095
7. Swales, K. and Negishi, M. (2004) CAR, driving into the future. Mol. Endocrinol. 18, 1589-1598
8. Li, H. and Wang, H. (2010) Activation of xenobiotic receptors: Driving into the nucleus. Expert Opin. Drug Metab. Toxicol. 6, 409-426
9. Osabe, M. and Negishi, M. (2011) Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. J. Biol. Chem. 286, 35763-35769
10. Chen, T., Tompkins, L. M., Li, L., Li, H., Kim, G., Zheng, Y. and Wang, H. (2010) A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3. J. Pharmacol. Exp. Ther. 332, 106-115
11. Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K. and Negishi, M. (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19, 6318-6322
12. Auerbach, S. S., Ramsden, R., Stoner, M. A., Verlinde, C., Hassett, C. and Omiecinski, C. J. (2003) Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res. 31, 3194-3207
13. Sueyoshi, T., Moore, R., Sugatani, J., Matsumura, Y. and Negishi, M. (2008) PPP1R16A, the membrane subunit of protein phosphatase 1β, signals nuclear translocation of the nuclear receptor constitutive active/androstane receptor. Mol. Pharmacol. 73, 1113-1121
14. Kobayashi, K., Sueyoshi, T., Inoue, K., Moore, R. and Negishi, M. (2003) Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol. Pharmacol. 64, 1069-1075
15. Mutoh, S., Osabe, M., Inoue, K., Moore, R., Pedersen, L., Perera, L., Rebolloso, Y., Sueyoshi, T. and Negishi, M. (2009) Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J. Biol. Chem. 284, 34785-34792
16. Hosseinpour, F., Moore, R., Negishi, M. and Sueyoshi, T. (2006) Serine 202 regulates the nuclear translocation of constitutive active/androstane receptor. Mol. Pharmacol. 69, 1095-1102
17. Yoshinari, K., Kobayashi, K., Moore, R., Kawamoto, T. and Negishi, M. (2003) Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett. 548, 17-20
18. Li, H., Chen, T., Cottrell, J. and Wang, H. (2009) Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): A novel tool for screening hCAR activators in human primary hepatocytes. Drug Metab. Dispos. 37, 1098-1106
19. Rencurel, F., Stenhouse, A., Hawley, S. A., Friedberg, T., Hardie, D. G., Sutherland, C. and Wolf, C. R. (2005) AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J. Biol. Chem. 280, 4367-4373
20. Marc, N., Galisteo, M., Lagadic-Gossmann, D., Fautrel, A., Joannard, F., Guillouzo, A. and Corcos, L. (2000) Regulation of phenobarbital induction of the cytochrome P450 2b9/10 genes in primary mouse hepatocyte culture. Involvement of calcium- and cAMP-dependent pathways. Eur. J. Biochem. 267, 963-970
21. Yamamoto, Y., Kawamoto, T. and Negishi, M. (2003) The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity. Arch. Biochem. Biophys. 409, 207-211
22. Mutoh, S., Sobhany, M., Moore, R., Perera, L., Pedersen, L., Sueyoshi, T. and Negishi, M. (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci. Signal. 6, ra31
23. Nawaz, Z. and O'Malley, B. W. (2004) Urban renewal in the nucleus: Is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol. Endocrinol. 18, 493-499
24. Keppler, B. R., Archer, T. K. and Kinyamu, H. K. (2011) Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription. Biochim. Biophys. Acta 1809, 109-118
25. Lin, H. K., Altuwaijri, S., Lin, W. J., Kan, P. Y., Collins, L. L. and Chang, C. (2002) Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 277, 36570-36576
26. Deroo, B. J., Rentsch, C., Sampath, S., Young, J., DeFranco, D. B. and Archer, T. K. (2002) Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22, 4113-4123
27. Auerbach, S. S., Dekeyser, J. G., Stoner, M. A. and Omiecinski, C. J. (2007) CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics. Drug Metab. Dispos. 35, 428-439
28. Omiecinski, C. J., Coslo, D. M., Chen, T., Laurenzana, E. M. and Peffer, R. C. (2011) Multi-species analyses of direct activators of the constitutive androstane receptor. Toxicol. Sci. 123, 550-562
29. Auerbach, S. S., Stoner, M. A., Su, S. and Omiecinski, C. J. (2005) Retinoid X receptor-α-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). Mol. Pharmacol. 68, 1239-1253
30. Goyak, K. M., Johnson, M. C., Strom, S. C. and Omiecinski, C. J. (2008) Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol. Appl. Pharmacol. 231, 216-224
31. Meiners, S., Ludwig, A., Stangl, V. and Stangl, K. (2008) Proteasome inhibitors: Poisons and remedies. Med. Res. Rev. 28, 309-327
32. Li, L., Chen, T., Stanton, J. D., Sueyoshi, T., Negishi, M. and Wang, H. (2008) The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl- methylpropyl)- 3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol. Pharmacol. 74, 443-453
33. Dekeyser, J. G., Stagliano, M. C., Auerbach, S. S., Prabu, K. S., Jones, A. D. and Omiecinski, C. J. (2009) Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant, CAR2. Mol. Pharmacol. 75, 1005-1013
34. Moore, J. T., Moore, L. B., Maglich, J. M. and Kliewer, S. A. (2003) Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta 1619, 235-238
35. Lonard, D. M. and O'Malley, B. W. (2009) Emerging roles of the ubiquitin proteasome system in nuclear hormone receptor signaling. Prog. Mol. Biol. Transl. Sci. 87, 117-135
36. Staudinger, J. L., Xu, C., Biswas, A. and Mani, S. (2011) Post-translational modification of pregnane X receptor. Pharmacol. Res. 64, 4-10
37. Song, Z. and Pollenz, R. S. (2002) Ligand-dependent and independent modulation of aryl hydrocarbon receptor localization, degradation and gene regulation. Mol. Pharmacol. 62, 806-816
38. Santiago-Josefat, B., Pozo-Guisado, E., Mulero-Navarro, S. and Fernandez-Salguero, P. M. (2001) Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Mol. Cell. Biol. 21, 1700-1709
39. Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663
40. Lonard, D. M., Nawaz, Z., Smith, C. L. and O'Malley, B. W. (2000) The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol. Cell 5, 939-948
41. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J. and Gannon, F. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707
42. Kang, Z., Pirskanen, A., Janne, O. A. and Palvimo, J. J. (2002) Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277, 48366-48371
43. Dennis, A. P., Lonard, D. M., Nawaz, Z. and O'Malley, B. W. (2005) Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. J. Steroid Biochem. Mol. Biol. 94, 337-346
44. Perissi, V., Aggarwal, A., Glass, C. K., Rose, D. W. and Rosenfeld, M. G. (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116, 511-526
45. vom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P. and Losson, R. (1996) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124
46. Ferry, C., Gianni, M., Lalevee, S., Bruck, N., Plassat, J. L., Raska, Jr, I., Garattini, E. and Rochette-Egly, C. (2009) SUG-1 plays proteolytic and non-proteolytic roles in the control of retinoic acid target genes via its interaction with SRC-3. J. Biol. Chem. 284, 8127-8135
47. Bhat, K. P. and Greer, S. F. (2011) Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation. Biochim. Biophys. Acta 1809, 150-155
48. Geng, F. and Tansey, W. P. (2012) Similar temporal and spatial recruitment of native 19S and 20S proteasome subunits to transcriptionally active chromatin. Proc. Natl. Acad. Sci. U.S.A. 109, 6060-6065